The shares most recently traded at $54.93, down $0.41, or 0.74% since the insider transaction. Historical insider transactions for Align Technology go as follows: The average volume for Align Technology has been 1.2 million shares per day over the past 30 days. Align Technology has a market cap of $4.4 billion and is part of the health care sector and health services industry. Shares are down 3.41% year-to-date as of the close of trading on Tuesday. Align Technology, Inc. operates as a medical device company primarily in the United States and internationally. The company has a P/E ratio of 70.5. Currently there are 5 analysts that rate Align Technology a buy, no analysts rate it a sell, and 4 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on ALGN - FREE TheStreet Quant Ratings rates Align Technology as a buy.